Effects of L-Tyrosine and Caffeine on Performance in Elite Boxers (TYCAF-BOX)

April 8, 2026 updated by: Halil UÇAR, Inonu University

Effects of L-Tyrosine and Caffeine Supplementation on Cognitive, Physical, and Physiological Parameters in Elite Boxers: A Randomized Double-Blind Placebo-Controlled Crossover Study

Participants will complete five sessions, including one familiarization and baseline session and four experimental conditions (placebo, L-tyrosine, caffeine, and combined supplementation). The baseline session will include resting measurements. The experimental conditions will be performed in a randomized, counterbalanced crossover design with a washout period of at least 72 hours between sessions.

Study Overview

Detailed Description

Participants will attend five sessions in total. The first session will be used for familiarization and baseline measurements, including resting physiological and cognitive assessments. The remaining four sessions will consist of randomized experimental conditions (placebo, L-tyrosine, caffeine, and combined supplementation), applied in a counterbalanced crossover design.

Each experimental session will be separated by a washout period of at least 72 hours. Supplements will be administered 60 minutes before exercise. Cognitive performance will be assessed using the Stroop test, and physical performance will be evaluated using a boxing-specific simulation protocol. Physiological responses, including heart rate and biochemical markers such as BDNF and oxidative stress parameters, will be measured.

Study Type

Interventional

Enrollment (Estimated)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Male elite boxers aged ≥18 years At least 8 years of boxing training experience Active participation in national or international competitions Regular training schedule No injury or illness affecting performance

Exclusion Criteria:

Use of nutritional supplements or stimulants within the last 4 weeks Any cardiovascular, metabolic, or neurological disorder Current injury or musculoskeletal limitation Smoking or excessive caffeine intake Failure to comply with study procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo
Participants receive placebo condition.
Placebo solution matched in taste and volume to active supplements.
Experimental: L-tyrosine
Participants receive L-tyrosine condition.
L-tyrosine at 150 mg/kg body weight administered 60 minutes before exercise.
Experimental: Caffeine
Participants receive caffeine condition.
Caffeine at 5 mg/kg body weight administered 60 minutes before exercise.
Experimental: Combined
Participants receive combined supplementation condition.
Combined L-tyrosine (150 mg/kg) and caffeine (5 mg/kg) administered 60 minutes before exercise.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stroop Test Performance
Time Frame: up to 12 weeks
Cognitive performance assessed using the Stroop test, including reaction time and accuracy.
up to 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BDNF Levels
Time Frame: up to 12 weeks
Serum brain-derived neurotrophic factor levels measured before and after exercise.
up to 12 weeks
Oxidative Stress Markers
Time Frame: up to 12 weeks
Serum levels of total antioxidant status (TAS), total oxidant status (TOS), malondialdehyde (MDA), superoxide dismutase (SOD) activity, and glutathione peroxidase (GPx) activity will be measured.
up to 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

April 1, 2026

First Submitted That Met QC Criteria

April 8, 2026

First Posted (Actual)

April 15, 2026

Study Record Updates

Last Update Posted (Actual)

April 15, 2026

Last Update Submitted That Met QC Criteria

April 8, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sports Performance

Clinical Trials on Placebo

Subscribe